Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Germany dismisses Seroquel XR

November 14, 2012 Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR

AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …
News

No specific targets in NHS mandate

November 14, 2012 Sales and Marketing CCGs, NHS, commissioning

The government has given the first public directive to the nascent NHS Commissioning Board, which assumes its new responsibilities from …
News

Eugene Washington appointed to J&J Board of directors

November 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ

Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …
Appointment

AstraZeneca signs genome deal

November 13, 2012 Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …
News

NHS Commissioning Board appoints Patients and Information directors

November 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coulthard, NHS, NHS Commissioning Board

The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …
Appointment

Pharma can help NHS transition, says partnership leader

November 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CCGs, Conference, NHS, PCT

A new ABPI team is now ready to help the pharmaceutical industry forge partnerships with the NHS, even as the …
Feature

Patients ‘shut out’ of drug price talks

November 13, 2012 Sales and Marketing Cancer, NHS, NICE, VBP, prostate

Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …
News

Pfizer and GSK end agreements

November 12, 2012 Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport

Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …
News

immatics appoints Peter Chambré as chairman

November 12, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Peter Chambre, immatics

Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …
Appointment

NHS: pharma needs to help more

November 12, 2012 Sales and Marketing CCGs, NHS, pharma

A variety of senior figures in public health set out how they want the pharma industry to do more to …
News

GSK guilty of off-label promotion

November 9, 2012 Medical Communications, Sales and Marketing GSK, PMCPA, Revolade

GlaxoSmithKline has been found to have breached three clauses in the ABPI Code of Practice following a complaint from a …
News

Pharma treated as though ‘selling cyanide’

November 9, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, Stephen Whitehead

APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …
News

Astellas appoints VP of Scientific and Medical Affairs

November 9, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss

Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …
Appointment

Leadership changes at Teva

November 8, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …
Appointment

Janssen and GSK in hep C tie-ups

November 8, 2012 Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026